To further assess whether our finding of GSK3A overexpression is relevant to human lung cancer, we used publically available Kaplan-Meier plotter (http://kmplot.com/analysis), which is consist of 1760 lung cancer patients who receive chemo/radiotherapy based on the databases (CARRAY: n = 504; GSE14814: n = 90; GSE19188: n = 156; GSE29013: n = 55; GSE31210: n = 246; GSE3141: n = 111; GSE37745: n = 196; GSE4573: n = 131; GSE8894: n = 138; and TCGA: n = 133). This evidence concerns the gene GSK3A and lung carcinoma.